Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 6/20 | 0.54 |
| ▸ | MAOB | P27338 | 3/20 | 0.54 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 4/20 | 0.42 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | KMO | O15229 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.37 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1033768 | 0.91 | KDM1A (0.46) | KDM1AMAOBHSD17B1HSD17B2GRM5 | |
| SCHEMBL1033011 | 0.81 | KDM1A (0.50) | KDM1AMAOBGRM5KMOCYP1A2 | |
| SCHEMBL19243067 | 0.81 | CCR1 (0.58) | KDM1AMAOBGRM5CNR2MAOA | |
| SCHEMBL19237524 | 0.77 | KDM1A (0.46) | KDM1AMAOBGRM5CNR2CYP1A2 | |
| SCHEMBL15060593 | 0.77 | RAB9A (0.51) | KDM1AMAOBGRM5CNR2 | |
| SCHEMBL20924015 | 0.75 | KDM1A (0.65) | KDM1AMAOBGRM5MAOA | |
| SCHEMBL18317728 | 0.74 | MEN1 (0.46) | MAOBHSD17B1HSD17B2 | |
| SCHEMBL379668 | 0.74 | PIK3CD (0.64) | PIK3CDCYP1A2MAP4K4KCNH2MINK1 | |
| SCHEMBL18573198 | 0.74 | LDHA (0.45) | KDM1AMAOBHSD17B1HSD17B2MAP4K4 | |
| SCHEMBL29099803 | 0.73 | HSD17B1 (0.50) | KDM1AMAOBHSD17B1HSD17B2CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2275409-A1 | Bipiridine derivative and organic electroluminescence element containing the same | Yamagata Promotional Organization for Industrial Technology (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327265-A1 | BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME | NFE2L2, SLC19A2, AOC2 | KDM1A 2647/4885MAOB 446/4885HSD17B1 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.